AOAngela Oxenius

Angela Oxenius

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Angela Oxenius has a total of 6 co-authors. Here are the top co-authors by number of shared publications:

  • Christian Balmer

    Pediatric Cardiology, Department of Surgery, Pediatric Heart Center, University Children’s Hospital, Zurich, Switzerland

    2 shared publications
  • Ali Dodge-Khatami

    Department of Congenital Cardiovascular Surgery, University Heart Center Hamburg, Hamburg, Germany

    1 shared publication
  • Anna Cavigelli-Brunner

    Division of Paediatric Cardiology, University Children’s Hospital Zurich, Zürich, Switzerland

    1 shared publication
  • Emanuela Valsangiacomo Buechel

    Division of Pediatric Cardiology , University Children's Hospital Zurich , Switzerland

    1 shared publication
  • Maja I. Hug

    Division of Intensive Care and Neonatology, University Children’s Hospital Zurich, Zurich, Switzerland

    1 shared publication
  • Urs Bauersfeld

    Division of Paediatric Cardiology, University Children’s Hospital Zurich, Zürich, Switzerland

    1 shared publication

Latest Publications

  • Do Predictors Exist for a Successful Withdrawal of Preoperative Prostaglandin E1 from Neonates with d-Transposition of the Great Arteries and Intact Ventricular Septum?

    by Angela Oxenius, Maja I. Hug, Ali Dodge-Khatami, Anna Cavigelli-Brunner, Urs Bauersfeld, Christian Balmer

    Prostaglandin E1 (PGE1) is given to neonates with d-transposition of the great arteries (d-TGA) to reduce cyanosis by reopening and maintaining the patency of the ductus arteriosus. To avoid side effects, this medication can be stopped for hemodynamically stable patients after balloon atrial septostomy (BAS). A consecutive series of neonates with d-TGA and an intact ventricular septum (IVS) presenting from 2000 through 2005 was analyzed retrospectively to search for side effects of PGE1 and to identify predictors for a safe preoperative withdrawal. The medication was stopped for hemodynamically stable patients with transcutaneous oxygen saturations higher than 80% after BAS and reinitiated for patients with an oxygen saturation lower than 65%. Patients successfully weaned were compared with those who had failed weaning in terms of atrial septal defect (ASD) size, ductus arteriosus size, and the transcutaneous oxygen saturation. Prostaglandin E1 was initiated for all 43 neonates with d-TGA. The median maintenance dose of PGE1 was 0.00625 μg/kg/min (range, 0.00313–0.050 μg/kg/min) for a median duration of 6 days (range, 1–12 days). For 16 patients, PGE1 was preoperatively withdrawn but then had to be reinitiated for 7 of the 16 patients. No predictors for a successful weaning of PGE1 were found based on ASD size, ductus arteriosus size, or oxygen saturation. The adverse effects of PGE1 were apnea in 10 patients and fever in 19 patients. Neither seizures nor necrotizing enterocolitis was documented. Prostaglandin E1 was successfully withdrawn for a minority of hemodynamically stable patients with d-TGA. No predictors for a successful weaning could be identified. Because apnea and fever are common side effects, withdrawal of PGE1 after BAS may improve patient safety and comfort. In this patient group, if PGE1 withdrawal was not well tolerated, it could be safely reinitiated. There were no serious side effects of PGE1.


  • Open Access

    Isolation of the right subclavian artery in interrupted aortic arch

    by Angela Oxenius, Christian Balmer, Emanuela Valsangiacomo Buechel

    A 15-day-old newborn presented with cardiovascular shock. Upon clinical suspicion of congenital heart disease (CHD), medical treatment was initiated. Echocardiography showed a left-sided interrupted aortic arch Type B and a large ventricular septal defect (VSD). Magnetic resonance imaging (MRI) was requested for preoperative exact anatomical delineation of the interrupted aortic arch and of its branches. Additionally, MR angiography depicted an isolated right subclavian artery originating from the right pulmonary artery (Figure). Two days later, the patient underwent successful surgical repair with reconstruction of the aortic arch, VSD-closure, and re-implantation of the right subclavian artery into the aortic arch.